Skip to main content

Cardlytics, Inc.

For the period ended Mar 31, 2026. Filed May 7, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 7, 2026

CDLX$1.63-10.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)

Three Months Ended March 31, 2026:

AdditionalPaid-InCapital · AccumulatedOtherComprehensive Loss · AccumulatedDeficit · Total
Common Stock
Shares · Amount
Balance – December 31, 202554,514$10$1,399,542$(1,996)$(1,404,064)$(6,508)
Stock-based compensation——5,521——5,521
Settlement of restricted stock557—————
Other comprehensive income———1,464—1,464
Net loss————(4,480)(4,480)
Balance – March 31, 202655,071$10$1,405,063$(532)$(1,408,544)$(4,003)

Three Months Ended March 31, 2025:

AdditionalPaid-InCapital · AccumulatedOtherComprehensive (Loss) Income · AccumulatedDeficit · Total
Common Stock
Shares · Amount
Balance – December 31, 202451,257$10$1,366,958$3,601$(1,300,576)$69,993
Stock-based compensation——9,734——9,734
Settlement of restricted stock918—————
Other comprehensive loss———(2,355)—(2,355)
Net loss————(13,282)(13,282)
Balance – March 31, 202552,175$10$1,376,692$1,246$(1,313,858)$64,090
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.